Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma.

Authors

Catherine M Bollard, George Washington UniversityFollow
Tamara Tripic
Conrad Russell Cruz
Gianpietro Dotti
Stephen Gottschalk
+several additional authors

Document Type

Journal Article

Publication Date

1-9-2018

Journal

Journal of Clinical Oncology

DOI

10.1200/JCO.2017.74.3179

APA Citation

Bollard, C., Tripic, T., Cruz, C., Dotti, G., Gottschalk, S., & +several additional authors (2018). Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma.. Journal of Clinical Oncology, (). http://dx.doi.org/10.1200/JCO.2017.74.3179

Peer Reviewed

1